4DMedical Limited (ASX:4DX)

Market Cap	905.04M
Revenue (ttm)	5.85M
Net Income (ttm)	-30.07M
Shares Out	500.02M
EPS (ttm)	-0.06
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	9,453,236
Average Volume	16,133,325
Open	1.755
Previous Close	1.750
Day's Range	1.715 - 1.855
52-Week Range	0.225 - 2.380
Beta	1.71
RSI	63.09
Earnings Date	Nov 27, 2025

About 4DMedical

4DMedical Limited operates as a medical technology company in the United States and Australia. It engages in the medical research technology and development of a non‑invasive respiratory imaging solution using four‑dimensional imaging. The company also offers X-ray velocimetry lung ventilation analysis software (XV LVAS), a lung airflow imaging software, that provides lung health detail from X-Ray scans; computed tomography lung ventilation analysis software (CT LVAS), an image processing software which operates on CT scans to provide functiona...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2012
• Employees: 145
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: 4DX

Financial Performance

In 2025, 4DMedical's revenue was 5.85 million, an increase of 55.91% compared to the previous year's 3.75 million. Losses were -30.07 million, -16.42% less than in 2024.